CEACAM5 and carcinoma: NEO-201 can exert a significant anti-tumor activity not only by inducing NK mediated ADCC or CDC, but also enhancing direct NK killing against CEACAM5+/NEO-201+ human carcinoma cells [28,29,30,31].